Watson, Sun Seek Attorneys' Fees From Novartis

Law360 (June 5, 2007, 12:00 AM EDT) -- A federal judge on Friday agreed to allow Watson Pharmaceuticals Inc. and Sun Pharmaceutical Industries Ltd. to seek attorneys' fees in an infringement suit brought by Novartis Pharmaceuticals Corp. over patents for Exelon, the Swiss drug maker’s Alzheimer’s treatment.

U.S. Magistrate Judge James C. Francis IV of the U.S. District Court for the Southern District of New York granted Watson and Sun leave to amend their counterclaims against Novartis to add a claim for attorneys’ fees with regards to one of the two patents-in-suit. The motion...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.